×

Biotech beatdown

5:53 PM ET Thu, 29 Sept 2016

Biotech stocks are under pressure as California proposes a "Drug Price Relief Act" to curb the high cost of drugs after Mylan's EpiPen controversy. The "Fast Money" traders share their views on the biotech sector.